stoxline Quote Chart Rank Option Currency Glossary
  
Enveric Biosciences, Inc. (ENVB)
1.68  0.2 (13.51%)    12-01 15:59
Open: 1.5
High: 1.68
Volume: 8,312
  
Pre. Close: 1.48
Low: 1.41
Market Cap: 4(M)
Technical analysis
2023-12-01 4:19:39 PM
Short term     
Mid term     
Targets 6-month :  2.05 1-year :  2.33
Resists First :  1.76 Second :  2
Pivot price 1.47
Supports First :  1.37 Second :  1.14
MAs MA(5) :  1.5 MA(20) :  1.56
MA(100) :  2.16 MA(250) :  2.37
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  37 D(3) :  26.7
RSI RSI(14): 47.7
52-week High :  6.98 Low :  1.29
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ENVB ] has closed below upper band by 0.2%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.59 - 1.6 1.6 - 1.6
Low: 1.46 - 1.47 1.47 - 1.48
Close: 1.47 - 1.48 1.48 - 1.49
Company Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Headline News

Wed, 29 Nov 2023
Enveric Biosciences Inc (ENVB) Stock Is Down 0.00% This Week: Buy, Hold, or Sell? - InvestorsObserver

Wed, 29 Nov 2023
Enveric Biosciences Receives Notice of Allowance from USPTO for ... - Manchestertimes

Mon, 27 Nov 2023
Enveric Biosciences Announces Manuscript Describing the ... - StreetInsider.com

Fri, 24 Nov 2023
Enveric Biosciences Announces Presentation of Two Posters at ... - Yahoo Finance

Mon, 13 Nov 2023
Enveric Biosciences Reports Third Quarter 2023 Corporate and ... - Yahoo Finance

Fri, 20 Oct 2023
Enveric Biosciences to Present at the Centurion One 5th Global ... - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 2 (M)
Shares Float 2 (M)
Held by Insiders 12.5 (%)
Held by Institutions 10.9 (%)
Shares Short 19 (K)
Shares Short P.Month 11 (K)
Stock Financials
EPS -11.52
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.12
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -61.5 %
Return on Equity (ttm) -173.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -7.79
Qtrly Earnings Growth 0 %
Operating Cash Flow -16 (M)
Levered Free Cash Flow -8 (M)
Stock Valuations
PE Ratio -0.14
PEG Ratio 0
Price to Book value 1.42
Price to Sales 0
Price to Cash Flow -0.24
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android